---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-017239"
form_type: "8-K"
ticker: "DMAC"
cik: "0001401040"
company_name: "DiaMedica Therapeutics Inc."
filed_at: "2025-05-15T23:59:59+00:00"
generated_at: "2026-05-21T04:44:15.928441+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# DiaMedica shareholders elect all 7 director nominees, ratify auditor, approve say-on-pay

## Summary
- Michael Giuffre, Rick Kuntz, Tanya Lewis, Daniel O'Connor, James Parsons, Rick Pauls, Charles Semba elected with 96.3% or more of votes cast.
- Appointment of Baker Tilly US, LLP as auditor for FY2025 approved with 95.5% of votes cast.
- Advisory vote on executive compensation passed with 94.1% of votes cast (excluding broker non-votes).
- Quorum reached with 45.1% of outstanding shares (19.34M of 42.86M) present at May 15, 2025 AGM.

## SEC filing metadata
- accession: 0001437749-25-017239
- form_type: 8-K
- ticker: DMAC
- cik: 0001401040
- company_name: DiaMedica Therapeutics Inc.
- filed_at: 2025-05-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401040/000143774925017239/0001437749-25-017239-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401040/000143774925017239/dmtp20250515_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-017239
- JSON: https://secwatch.observer/filing/0001437749-25-017239.json
- Plain text: https://secwatch.observer/filing/0001437749-25-017239.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.